Team Pharmaceuticals Ltd. has expanded its gastroenterology portfolio with the launch of Exipid 50, containing Itopride Hydrochloride 50 mg. This new product reinforces the company’s commitment to delivering effective and affordable treatment options for gastrointestinal motility disorders.
Exipid 50 is indicated for the management of functional dyspepsia and related gastrointestinal symptoms by enhancing gastric motility and improving digestive function. Manufactured at Team Pharmaceuticals’ modern, GMP-compliant facility in Rajshahi, the product meets stringent quality and safety standards to ensure consistent therapeutic performance.
The launch of Exipid 50 reflects the company’s ongoing focus on addressing unmet clinical needs through reliable generic formulations. By combining proven active ingredients with robust manufacturing and quality assurance systems, Team Pharmaceuticals continues to support healthcare professionals with dependable treatment choices.
Management noted that the introduction of Exipid 50 aligns with the company’s strategy of portfolio expansion in high-demand therapeutic areas. With this addition, Team Pharmaceuticals further strengthens its presence in gastroenterology and reaffirms its dedication to quality, compliance, and patient-centered healthcare solutions.
